Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653157 · ClinicalTrials.gov registry record
Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn
A clinical trial of Multi-drug Resistant Gram-negative Bacilli Colonization, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT02653157 is a study of Multi-drug Resistant Gram-negative Bacilli Colonization that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02653157, a study of Multi-drug Resistant Gram-negative Bacilli Colonization, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.
Conditions Studied
Interventions
- OTHER MDR-GNB
Study Locations (1)
North Carolina
- University of North Carolina Jaycee Burn Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02653157
The ClinicalTrials.gov registry entry for NCT02653157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multi-drug Resistant Gram-negative Bacilli Colonization appearing as the primary indexed condition, and to 1 intervention - of which MDR-GNB is the first listed.
NCT02653157 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02653157 about?
NCT02653157 is a clinical study titled "Multidrug Resistant Gram-negative Bacilli Colonization and Infection in Burn". This is a prospective observational study to determine the role of colonization and identify the timing of development of drug resistance in multidrug resistant Gram-negative bacilli (MDR-GNB) causing infection among critically ill burn patients.
What is the current status of trial NCT02653157?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2015-10. Estimated completion is 2017-12.
What conditions does trial NCT02653157 study?
This clinical trial studies the following conditions: Multi-drug Resistant Gram-negative Bacilli Colonization.
What interventions are being tested in trial NCT02653157?
The interventions under investigation include: MDR-GNB (OTHER).
Who is sponsoring clinical trial NCT02653157?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02653157 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.